TB is a dangerous disease that affects about 9 million people worldwide every year. Among them, only 32% of people in India are affected by this disease. It costs billions of dollars in treatment.
Tuberculosis Remedies Invented: TB or tuberculosis is an infectious disease that remains inactive for many days before becoming contagious. But the problem with TB is that many people do not even know it can be contagious. White blood cells are known as macrophages, which are similar to other infections and also fight tuberculosis bacteria. But in this case, the bacteria are not killed, but create structures in the form of a bag, which is called granuloma. The bacteria are inactive for a long time with their presence. But due to other illnesses such as physical impairment or HIV, the (pouch) granuloma can burst as the ability to fight your disease decreases. In this case, tuberculosis can escape from the infection and have a big effect on your body.
You must have heard of isoniazid as it is the most common treatment for tuberculosis. Active TB, if it is a drug-resistant strain, requires a series of drugs at the same time. Below we present you the most common drugs for the treatment of tuberculosis. It contains: Isoniazid. Rifampin (Rifadin, Rimactane)
How is tuberculosis cured?
Also read: Signs of Pregnancy in Nursing Mothers
A research team from the CSIR-Indian Institute of Chemical Biology, the Bose Institute of Calcutta and Jadavpur University has found out how tuberculosis is infected by macrophages in the human body. This study is being studied by several researchers around the world.
According to the team, the bacteria remove proteins called MPT63 from the body and play a key role in the spread of tuberculosis. Sometimes the structure of this protein changes and suddenly it becomes responsible for the host cells, i. H. macrophages, poisonous. It destroys the cells and spreads bacteria in the body.
Also read: PM Modi, Akshay Kumar, Virat Kohli Make a Place in the List of Health Influences of GOQii 2019
Dr. Krishnanand Chattopadhyay, head and team leader of the Department of Structural Biology and Bioinformatics at IICB, told Science Wire that his team will now try to exploit this research in tuberculosis bacilli to see whether or not new medical interventions can be developed.  With this discovery, researchers can now look for new ways to reduce the effects of MPT63 protein, permanently prevent tuberculosis, and save millions of tuberculosis patients. The research team consisted of Achinta Sanyagrahi, Indrani Nandi, the Sayantini Challenge, Junaid Jibran Javed, Animesh Halder, Subrata Mazumdar and Sanat Karmakar.
After completing the remaining exams, results will be published in the ACS Chemical Biology Journal.
Read more Articles on Health News
Written by: Tavishi Dogra
Source: Onlymyhealth Editorial Team July 19, 2019